NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Wyeth Names Communications VP
Wyeth, Madison, N.J., has promoted Wendy Kouba to VP, cor porate communications, from VP, communica tions, technical operations and product supply. In this new role, Ms. Kouba oversees the company’s global public relations and communications functions, including issues management, media relations, product publicity, internal communications, community relations, and corporate contributions. Ms. Kouba holds a B.A. in journalism and psychology from the University of Mas sachusetts at Amherst, and she completed the executive development program at the Uni versity of Pennsylvania’s Wharton School of Business. Dr. Barbara LEWIS Dr. Kimberly RAY Eisai Announces Staff Additions Eisai Inc., Woodcliff Lake, N.J., a United Statesbased subsidiary of Japan’s Eisai Co., has appointed Kimberly Ray, Ph.D., senior manag er, pharmacoepidemiology and risk manage ment in medical services. Dr. Ray was previous ly associate manager, global pharmacovigilance and epidemiology at BristolMyers Squibb. She received a B.S. in animal science from California Polytechnic State University and a Ph.D. in comparative biomedical sciences with concentrations in epidemiology and infectious disease from Cornell University. Barbara Lewis, Ph.D., MHA, has joined another U.S. subsidiary, Eisai Cor poration of North Ameri ca, as director, global health economics and out comes research (HEOR), from AstraZeneca, where she was a fieldbased HEOR director primarily working with man agedcare organizations and large medical groups in the northeast. Dr. Lewis received an undergraduate degree in psychology and English from the State University of New York at Albany, and a Ph.D. in psychology and an MHA from Clark University. Dr. Alan MOSES Novo Nordisk Names Global Medical Chief Novo Nordisk has promoted Alan Moses, M.D., to VP, chief medical officer worldwide, from his previous position as chief medical officer of Novo Nordisk Inc., the company’s U.S. affiliate. In the newly expanded role, Dr. Moses works closely with senior colleagues in Denmark to provide clinical and medical affairs expertise and serve as the principle voice of clinical science for the company worldwide. He received a B.S. from Duke University and an M.D. from Washington University School of Medicine. (Editor’s note: An exclusive PharmaVOICE interview with Dr. Moses appears in this issue’s Last Word on page 94) Steven SEMBLER Roche Promotes Senior Manager Roche, Nutley, N.J., has promoted Steven Sembler to VP of commercial operations, responsible for overseeing U.S. marketing and sales for products in key therapeutic areas, TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY including oncology, HIV, hepatitis, and infec tion. Mr. Sembler replaces Gary Zieziula, who was named the new general manager of Roche in Greece. Mr. Sembler was previously VP, oncology, responsible for Roche’s U.S.based oncology business. He received a B.A. from the Univer sity of Missouri. Andrew SKIBO Dr. JoAnn SUZICH MedImmune Expands Engineering,Research Leadership MedImmune, Gaithersburg, Md., has made two additions to its executive roster as it continues to solidify its role as the global bio logics unit for AstraZeneca. Andrew Skibo has joined MedImmune as senior VP, engineering, from Amgen, where he served as VP, corporate engineering and capital projects. Mr. Skibo is responsible for overseeing largescale capital projects at all of MedImmune’s facilities, including sites in California, Pennsylvania, Maryland, the Netherlands, and the United Kingdom, as well as the ongoing construction of the com pany’s antibodymanufacturing facilities in Frederick, Md. He received a B.S. in organic chemistry and an M.S. in chemical engineer ing with a specialty in biomedical engineer ing, both from the Massachusetts Institute of Technology. MedImmune also has promoted company veteran JoAnn Suzich, Ph.D., to VP, research and development, infectious disease. Since joining MedImmune in 1988 as a scientist, Dr. Suzich has held several positions of increasing responsibility, most recently as senior director, infectious disease research. She received a B.S. in biology from Susquehanna University and a doctorate in biochemistry from Purdue University. Biopharmaceutical POOL Dr. Gordon BRANDT New President at Nastech Gordon Brandt, M.D., has been promot ed to president of Nastech Pharmaceutical, Bothell, Wash., from executive VP, clinical research and medical affairs. He replaces PV0308 LAYOUT 2/14/08 5:44 PM Page 88 89 PharmaVOICE M a r c h 2008 TALENT pool Steven Quay, M.D., Ph.D., who remains Nastech’s chairman and CEO. Dr. Brandt joined Nastech in 2002 from oncology drug developer Sonus Pharmaceuti cals. He received a B.S. in engineering science and an M.D. from the University of California, San Francisco. Barry GREENE New President Named at Alnylam Alnylam Pharmaceu ticals, a Cambridge, Mass.based developer of RNA interference (RNAi) therapeutics, has promoted its chief oper ating officer, Barry Greene, to the position of president and chief oper ating officer. In this new role, Mr. Greene assumes responsibility for business, corporate, and commercial development activities at Alnylam. Mr. Greene joined Alnylam in 2003 from Millennium Pharmaceuticals, where he was general manager of oncology. He received a B.S. in industrial engineering from the Uni versity of Pittsburgh, and is a senior scholar at Duke University’s Fuqua School of Business. Dr. Alan HARRIS NPS Appoints Medical Chief NPS Pharmaceuticals, Bedminster, N.J., has named Alan Harris, M.D., Ph.D., senior VP and chief medical officer. Initially, he is leading the company’s research and develop ment programs for product candidates Gattex for severe gastrointestinal disorders, Preos for osteoporosis, and NPSP156 for epilepsy, neu ropathic pain, and other CNS disorders. Most recently, Dr. Harris was chief medical officer at Manhattan Pharmaceuticals. He received a doctor of medicine degree from the University of Strasbourg, France, and a Ph.D. in endocrinology from Erasmus University, the Netherlands. Dr. Jeffrey MCKELVY ItherX Appoints New CEO Following Name Change ItherX Pharmaceuticals, formerly known as Immusol, has named Jeffrey McKelvy, M.D., Ph.D., president and CEO. Dr. McKelvy suc ceeds cofounder Tsvi Goldenberg, Ph.D., who served as CEO of Immusol until July 2007 and remains chairman of ItherX. Immusol Cofounder Flossie WongStaal, Ph.D., remains executive VP of research and chief sci entific officer at ItherX. The name change and appointment of Dr. McKelvy as CEO reflects ItherX’s evolution from discovery research to an integrated bio pharmaceutical company. ItherX’s pipeline focuses on two major programs, oncology and virology. Most recently, Dr. McKelvy was president and chief technical officer at Avera Pharma ceuticals, where he had been founding CEO. He received a Ph.D. in biochemistry from Johns Hopkins University and an M.D. from Case Western Reserve University. Dennis SMITH Solstice Chairman Assumes CEO Role Solstice Neurosciences, Malvern, Pa., has appointed its chairman, Dennis Smith, as president and CEO. Mr. Smith was most recently president and CEO of specialty phar maceutical company INO Therapeutics. He is a graduate of Michigan State University and the Lake Forest Graduate School of Business. Specialty POOL Dr. Remis BISTRAS EyeGate Pharma Adds to Senior Management EyeGate Pharma, a specialty pharmaceutical company focused on developing therapeutics for ocular indications and based in Waltham, Mass., has appointed Remis Bistras, Ph.D., as VP, business develop ment. Dr. Bistras was previously senior consul tant at S.M. Jagger Consulting, and director, business development licensing at Ciba Vision, the eye care division of Novartis. He received an MBA from Carnegie Mellon Uni versity and a Ph.D. in psychology from Moscow University. Dr. George MOONSAMMY NuPathe Appoints VP of Development NuPathe, a Conshohocken, Pa.based spe cialty pharmaceutical company developing innovative products for the treatment of neu rological and psychiatric diseases, has named George Moonsammy, Ph.D., VP of develop ment. Dr. Moonsammy most recently served as senior VP, clinical, regulatory, and medical affairs at Somerset Pharmaceuticals, where he spearheaded the NDA filing and approval of Emsam, the first transdermal product for the treatment of patients with depression. Dr. Moonsammy received a B.S. in chem istry/biology from St. Louis University, an M.A. in neurobiology from the Washington University School of Medicine, and a Ph.D. in pharmacology from the Union Institute and University. Discovery POOL Dr. Jane DANCER Cellzome Names Business Development VP Cellzome has appointed Jane Dancer, Ph.D., as VP, business development. Cellzome is a drug discovery com pany with a holding company based in Boston. Dr. Dancer was previ ously director, business development, at Med Immune, formerly Cambridge Antibody Technology. She received an MBA from The Judge Institute of Management Studies, Uni versity of Cambridge, and a Ph.D. in natural sciences from the University of Cambridge. Association POOL Dr. Stephen DECHERNEY David SPAIGHT ACRO Elects 2008 Officers The Association of Clinical Research Orga nizations (ACRO), a Washingtonbased group representing the clinical outsourcing industry, has announced its new officers for 2008. Stephen DeCherney, M.D., MPH, chief innovation officer at Quintiles Transnational, PV0308 LAYOUT 2/14/08 5:44 PM Page 89 90 M a r c h 200 8 PharmaVOICE TALENT pool has been named chairmanelect of ACRO. Dr. DeCherney received a B.A. in biology from Columbia University and a medical degree from Temple University, as well as an MPH in healthcare management from Columbia Uni versity School of Public Health. David Spaight, president of MDS Pharma Services, has been elected chairman of ACRO. Mr. Spaight received a B.S. in chemistry and an MBA from the University of Michigan. Peter INCHAUTEGUIZ AAPS Announces Executive Promotion The American Asso ciation of Pharmaceutical Scientists (AAPS), Arlington, Va., has pro moted Peter Inchauteguiz to associate executive director, with responsibility for moni toring and advising exec utive director John Lisack Jr. on management issues, business development, and the organi zation’s growth and operational direction. AAPS is a professional, scientific organiza tion that offers its more than 13,000 members timely scientific programs, ongoing educa tion, information resources, opportunities for networking, and professional development. Mr. Inchauteguiz has served as the associa tion’s director of marketing and member ser vices for the past six years. He received a B.S. in management science from Virginia Poly technic Institute and State University. Dr. Chris PASHOS ISPOR Elects President The International Society for Pharmacoeco nomics and Outcomes Research (ISPOR), Cambridge, Mass., has elected Chris Pashos, Ph.D., as its president for 20082009. ISPOR is a scientific and educational organization that promotes the science of health economics and outcomes research, and the effective use of this research to help ensure fair and efficient use of healthcare budgets. Its more than 3,600 members include researchers, policymakers, and healthcare providers from 90 countries. Dr. Pashos is VP at Abt Associates and cre ator and leader of its Health Economic Research & Quality of Life Evaluation Services practice, which collaborates internationally with clinicians, researchers, and policymakers to assess the use, outcomes, and value of medicines and medical devices. He received a B.S. from the United States Naval Academy and a Ph.D. and M.P.P. in public policy from Harvard University. Agency POOL Lynne BRUM Porter Novelli Adds Executive VP Porter Novelli Life Sciences, San Diego, has appointed Lynne Brum executive VP, with responsibility for leading the expansion of the agency’s lifesciences practice in Boston. Ms. Brum was previously VP of strategic communications at Vertex Phar maceuticals. She received a B.A. in biological sciences from Wellesley College and an MBA from Simmons Graduate School of Manage ment. Don BRUNS Jedd DAVIS Ron WESSELS Creative Staff Grows at Avenue A | Razorfish The Philadelphia office of Avenue A | Razorfish has added three new staff members to its growing team of creative professionals. Don Bruns has been appointed user expe rience lead, responsible for managing the staff of information archi tects, experience researchers, and content strategists. Mr. Bruns previously worked as a consultant to various federal agen cies in the Washington, D.C., area. He is a grad uate of the University of Maryland. Jedd Davis has joined Avenue A | Razorfish as strategy director from SFGT, where he was director of media strate gies. Mr. Davis received a B.A. in cultural anthro pology from Washing ton University and an M.A. in media studies from the New School University. Ron Wessels has been named associate creative director with a specific focus on the copywriting side. Mr. Wessels was previously an associate creative director with Flashpoint DBC. He received a B.A. in journalism and mar keting from the University of Arkansas. Elisa COOPERBROSKI Corbett Accel Selects Marketing Chief Elisa CooperBroski has joined Omnicom Group’s Corbett Accel Healthcare Group, Chicago, as executive VP and chief marketing officer. Ms. CooperBroski is based in Corbett Accel’s New York office and is responsible for directing the agency’s business development strategy and leading the brandbuilding efforts for its five business units. Ms. CooperBroski was previously presi dent and chief branding officer at Bruce Leeb & Co. She received two B.A. degrees, in visual communications and art education, from Kean University. Gregg GEIDER Kirsten HANTON Mardene MILLER Harrison and Star Promotes Three Harrison and Star, New York, an Omni com Group agency, has announced the promo tions of three key executives in client services. Gregg Geider, Kirsten Hanton, and Mardene Miller have each been promoted to the posi tion of senior VP, managing director, from director of client services for various agency accounts. Chau HO Katie MOFFETT Phillip QUINDARA Palio Announces Staff Additions Palio, Saratoga Springs, N.Y., an inVentiv Health com pany, has made a num ber of additions to its staff. Chau Ho joins Palio as brand designer from Eric Mower and Associ ates, where he was associate art director. He received a bachelor’s degree from Rensselaer Polytechnic Institute. Katie Moffett has been appointed account PV0308 LAYOUT 2/14/08 5:44 PM Page 90 91 PharmaVOICE M a r c h 2008 TALENT pool executive. She was previ ously program facilitator at EdVenture Partners. She received a bachelor’s degree from the Univer sity at Albany. Phillip Quindara joins Palio as account supervisor from Media Logic, where he was an account supervisor responsible for the agen cy’s businesstobusiness account roster. He received a bachelor’s degree from the State University of New York at Cortland. David SCHULL Russo Partners Appoints President Russo Partners, New York, has promoted David Schull to presi dent.Mr. Schull previous ly served as managing director and senior VP of the San Diego office of Russo Partners’ predeces sor, Noonan Russo. CRO POOL Charles STEVENS Parexel Appoints Executive to Health Policy Unit Parexel International, Boston, has named Charles Stevens VP and general manager of Health Policy and Strate gic Reimbursement Ser vices, a unit based in the Washington, D.C. area. Mr. Stevens’ responsi bilities include managing reimbursement ser vice and patient assistance programs and over seeing the company’s reimbursement strategy consulting practice. He has held seniorlevel reimbursement positions at Cephalon and Cell Therapeutics. He received a bachelor’s degree from Northeastern University, an MBA from Clark University, and a juris doctor degree from Suf folk University Law School. Dr. Patricia WOZNIAK ACRS Names Statistical Programming Supervisor Advanced Clinical Research Services (ACRS), Bannockburn, Ill., has appointed Patri cia Wozniak, Ph.D., as director, statistical pro gramming. Dr. Wozniak previously served as asso ciate director of statistics for Abbott Laboratories’ Global Pharmaceuti cal Research and Development group. Media POOL Karen CLEMMENTS Sean KEATING Kerry ROBINSON Advanstar Makes Management Changes at ModernMedicine Advanstar Communications, Woodcliff Lake, N.J., has announced several key man agement changes related to its Modern Medicine Web portal, in line with Advanstar’s goal of continued business growth from a tra ditional print publisher to a comprehensive online destination for healthcare professionals. Karen Clemments has assumed the role of managing editor of modernmedicine.com, with responsibility for assisting in product development and management and leading the daytoday management of editorial con tent on the ModernMedicine site. Ms. Clem ments most recently worked on the print and electronic versions of Patient Care and Geri atrics magazines for Advanstar. Sean Keating is now product director for Modern Medicine. In his previous role as managing editor of Med ical Economics, Mr. Keating developed med blogger.net, a site dedi cated to news and opin ions impacting primary care physicians. Kerry Robinson has been named director of sales for ModernMedicine. He previously served as publisher of Patient Care. James SILVERMAN New Sales VP at MediZine MediZine, a New Yorkbased consumer health educational mar keting firm, has appoint ed James Silverman as VP, sales and marketing. Mr. Silverman was most recently director of health association busi ness development and sales director at Health Monitor Network. He received a BBA from Drake College. Kenneth SYLVIA New Publisher for DHM’s Current Psychiatry Dowden Health Media, Montvale, N.J., a subsidiary of LebharFriedman, has announced the addition of Kenneth Sylvia as publisher of the peerreviewed journal Current Psychiatry. Mr. Sylvia has launched a number of med ical publications during his career, including the Journal of Critical Illness and Women’s Health in Primary Care. Most recently, Mr. Sylvia was part of the team at Hearst Business Media’s Diversion. MedicalEducation POOL Dr.Thaddeus OBLOY Dr. Scott SALSMAN Selva Group Announces Staff Expansion The Selva Group, Saratoga Springs, N.Y., an inVentiv Health company, has announced several new hires. Thaddeu s Ob l oy, Ph.D., has been named director of educational design and curriculum d e v e l o p m e n t . H e received a bachelor’s degree and Ph.D. from Ohio University, and a master’s degree from Case Western Reserve University. Scott Salsman, Ph.D., joins Selva as medi cal writer from Shaw Science Partners, where PV0308 LAYOUT 2/14/08 5:44 PM Page 91 92 M a r c h 200 8 PharmaVOICE TALENT pool he was a senior research associate. Dr. Salsman received a master’s degree and Ph.D. from the Universi ty of Oklahoma, and a bachelor’s degree from Northeastern State Uni versity. Service POOL Peter BLACK David SECKER PRO Consulting Announces Management Expansion PRO Consulting, a Pittsburghbased divi sion of Invivodata specializing in patient reported outcomes (PRO) services, has expanded its management team in response to growing business needs. Peter Black has been promoted to the newly created role of VP, opera tions, responsible for leading the organization’s growth, including the staffing and oversight of all projects. Mr. Black has more than 20 years of clinical research experience and has served as a senior scientific consultant with PRO Consult ing. He holds a B.S. in psychology and an M.S. in health sciences. David Secker has been promoted to com mercial director at PRO Consulting, from his previous position as invivodata’s director of business development for the United King dom. In his new role, Mr. Secker is responsible for managing all business relationships with PRO Consulting clients. He received a diploma and M.A. in clinical psychology from Massey University in New Zealand. Gregg CIARELLI Wolters Kluwer Health Names VP for Source Product Line The Pharma Solutions business of Wolters Kluwer Health, Conshohocken, Pa., a division of Wolters Kluwer, has appointed Gregg Cia relli VP for its Source line of sales effectiveness products primarily geared toward helping pharmaceutical compa nies manage targeting and compensation activi ties. Mr. Ciarelli is based in Wolters Kluwer Health’s Yardley, Pa., office. Most recently, Mr. Ciarelli was executive director, sales administration at Boehringer Ingelheim Pharmaceuticals. He received a BBA in marketing and accounting from Tem ple University and MBAs in finance and phar maceutical marketing from Saint Joseph’s University. Dr. Erik COATS Robert RAMIREZ Observant Enhances Pharma Expertise Located in Waltham, Mass., Observant, a mar keting consulting and research management company, has appointed VP Eric Coats, Ph.D., a full managing partner of the firm. Since joining Observant in 2005, Dr. Coats has focused on assisting pharmaceutical clients in bringing new products to market. He holds a Ph.D. in social psychology with a con centration in quantitative analysis. In addition, Robert Ramirez has joined Observant as a director, with global responsibili ty for market research and consulting engage ments, as well as strengthening the com pany’s alignment of mar keting strategy with business processes. Mr. Ramirez was previously a senior manager in Pfizer’s global market analytics division. He received an MBA in healthcare administration with a concentration in hospital management from Sacred Heart University. Dr. James KRAMER New Operations VP at BioReliance BioReliance, a Rockville, Md. company providing biologics testing and diagnostic ser vices, has announced the appointment of James Kramer, Ph.D., as VP of operations, U.S. biologics, with direct responsibility and accountability for all aspects of U.S. biologics service delivery, quality and performance, employee development and career progression, and materials management functions. Most recently, Dr. Kramer served as senior VP/general manager, Talecris Plasma Resources, for Talecris Biotherapeutics. Dr. Kramer earned a bachelor’s degree in biology at Kean University and a doctorate in biochemistry at the University of Medicine and Dentistry of New Jersey. Mark STEVENSON Applied Biosystems Completes Management Transition Mark Stevenson has been promoted presi dent and chief operating officer of Applied Biosystems Group, an operating group of Applera based in Foster City, Calif. He suc ceeds Applera’s chairman, president, and CEO, Tony White, who has served as interim president of Applied Biosystems since Octo ber 2006. Mr. Stevenson, who has also been named a senior VP of Applera, was previously executive VP of Applied Biosystems, responsible for oversight of Europe, Japan, Global Services, and the Applied Markets business. His new position adds the Proteomics and Small Molecule (PSM) division and the AsiaPacific region to these responsibilities. Mr. Stevenson joined Applied Biosystems Europe in 1998 after previous positions with other lifesciences companies. He received a bachelor’s degree in chem istry from the University of Reading and an MBA from Henley Management School, both located in the United Kingdom. Technology POOL Rene PHARISIEN DecisionView Appoints New Sales Chief DecisionView, a San Franciscobased provider of clinicaltrial software solutions, has named Rene Pharisien VP of worldwide sales. Mr. Pharisien most recently served as senior VP of worldwide sales at Kintera. # Send your personnel announcements to email@example.com. PV0308 LAYOUT 2/14/08 5:44 PM Page 92